HALISTER: Novo Nordisk Soars on Plans to Resubmit Rejected Insulin to FDA

Novo Nordisk Soars on Plans to Resubmit Rejected Insulin to FDA

Alert: HALISTER Source: BN (Bloomberg News)

Tickers 3400398Z US (HHS Food & Drug Administration) NOVOB DC (Novo Nordisk A/S) SAN FP (Sanofi)

People Jeffrey Holford (Jefferies LLC) Lars Sorensen (Novo Nordisk A/S) Philippe Lanone (Natixis SA)

Topics Diabetes

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283

HALISTER1: Seeking Alpha: ETF To Avoid: Guggenheim S&P Global Dividend Opportunities ETF

Seeking Alpha: ETF To Avoid: Guggenheim S&P Global Dividend Opportunities ETF

Alert: HALISTER1 Source: BLG (Blogs Web Content)

Tickers LVL US (Guggenheim S&P Global Dividend Opportunities Index ETF) FGD US (First Trust DJ Global Select Dividend Index Fund) SDIV US (Global X SuperDividend ETF) WDIV US (SPDR S&P Global Dividend ETF) DEW US (WisdomTree Global Equity Income Fund)

To de-activate this alert, run {NLRT DEACT HALISTER1 <GO>}. To modify this alert, run {NLRT EDIT HALISTER1 <GO>}.

UUID: 7947283